You are using an out of date browser. It may not display this or other websites correctly. You should upgrade or use an alternative browser.
adb
ADB-HEXINACA (also known as ADB-HINACA and ADMB-HEXINACA) is a cannabinoid designer drug that has been found as an ingredient in some synthetic cannabis products, first appearing in early 2021. It is a longer chain homologue of previously encountered synthetic cannabinoid compounds such as ADB-BUTINACA and ADB-PINACA. The pharmacology of ADB-HEXINACA and numerous analogues at CB1 and CB2 receptors has been reported.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.